Product Information
COLESEVELAM HCL 3.75 G PACKET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.7596 per EA under NDC 68462062030. Its NADAC has been published 410 times since Oct 17, 2018.
FDA first approved this application on Jul 16, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3.75 g/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462062030
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202190FDA Approved
7/16/2018
TE Code
AB
On Market Since
7/16/2018
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM HCL 3.75 G PACKET has been published 410 times since Oct 17, 2018, and over the history we have for it it has declined 81.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7596 per EA |
|---|---|
| All-time high | $15.5351 (Feb 13, 2019) |
| All-time low | $2.4176 (May 20, 2026) |
| 52-week high | $2.7662 |
| 52-week low | $2.4176 |
| Median price | $5.6216 |
| Average price | $6.8132 |
| Largest weekly change | +44.2% (Feb 23, 2022) |
| Weeks tracked | 410 |
| Tracking since | Oct 17, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Colesevelam Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COLESEVELAM HCL 3.75 G PACKET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM HCL 3.75 G PACKET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.7596 per EA (NDC 68462062030), effective Aug 19, 2026.
How has the price of COLESEVELAM HCL 3.75 G PACKET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM HCL 3.75 G PACKET has declined 81.5%. It has been tracked across 410 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for COLESEVELAM HCL 3.75 G PACKET?
Since Oct 17, 2018, the NADAC for COLESEVELAM HCL 3.75 G PACKET has ranged from a low of $2.4176 (May 20, 2026) to a high of $15.5351 (Feb 13, 2019), with a median of $5.6216 per EA.
Are there cheaper alternatives to COLESEVELAM HCL 3.75 G PACKET?
No other NADAC-published product currently shares the active ingredient and strength of COLESEVELAM HCL 3.75 G PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COLESEVELAM HCL 3.75 G PACKET?
COLESEVELAM HCL 3.75 G PACKET (NDC 68462062030) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.